Similarities and differences in mechanisms of cardiotoxins, melittin and other myotoxins.
Myonecrosis induced in vivo by cardiotoxin, melittin, and Asp49 and Lys49 phospholipase A2 (PLA2) myotoxins involves rapid lysis of the sarcolemma, myofibril clumping, and hypercontraction of sarcomeres. In contrast, skeletal muscle necrosis induced by crotamine and myotoxin a is much slower, consisting of mitochondrial and sarcoplasmic reticulum swelling, myofibril degeneration, and lack of sarcolemma or transverse tubule damage. The mechanisms contributing to the myonecrosis induced by these peptides were evaluated. Two cardiotoxins and two Lys49 PLA2 myotoxins lysed primary cultures of human skeletal muscle within 24 hr at a concentration of 0.25 microM, while melittin, crotamine, and myotoxin a, and an Asp49 PLA2 myotoxin were non-cytolytic at concentrations up to 5.0 microM, suggesting that cytolysis is not a good measure of myotoxicity. Crotamine and the Lys49 PLA2 myotoxin altered Ca2+ ion flux in human heavy sarcoplasmic reticulum by opening the ryanocine receptor. Whole-cell patch-clamp studies demonstrated that administrating crotamine intracellularly increased Na+ currents. Free fatty acids, liberated by activation of tissue phospholipase C or by the PLA2 activity of the myotoxins, were monitored for crotamine, myotoxin a and a Lys49 PLA2 myotoxin in cell cultures in which the lipids had been radiolabeled. Only the Lys49 myotoxin produced significant amounts of fatty acid in cell cultures, supporting a potential role for fatty acid production only in the mechanism of sarcolemma-destroying myotoxins. These findings, coupled with those in the literature, support a hypothesis in which the myotoxins and/or products of lipase activity (e.g. fatty acids) are acting at a site existing on both the Na+ channel and a protein involved in Ca2+ release and probably serving a modulatory function for ion regulation. Based on the similarities in mechanisms between the toxins and fatty acids, the most likely site would be a fatty acid binding site on the protein (either similar to that on fatty acid binding proteins, or an acylated cysteine residue) or in the membrane.
Fletcher
J E
JE
Department of Anesthesiology, Medical College of Pennsylvania, Philadelphia 19102-1192, USA.
Hubert
M
M
Wieland
S J
SJ
Gong
Q H
QH
Jiang
M S
MS
D001514:Bee Venoms / Q000633:toxicity; D016923:Cell Death / Q000187:drug effects; D002458:Cell Fractionation; D002478:Cells, Cultured; D004179:Cobra Cardiotoxin Proteins / Q000633:toxicity*; D004546:Elapid Venoms / Q000633:toxicity; D004789:Enzyme Activation; D006801:Humans; D008049:Lipase / Q000378:metabolism; D008555:Melitten / Q000633:toxicity*; D009498:Neurotoxins / Q000633:toxicity*; D010741:Phospholipases A / Q000378:metabolism; D054467:Phospholipases A2; D012519:Sarcoplasmic Reticulum / Q000187:drug effects; D015222:Sodium Channels / Q000187:drug effects; D013329:Structure-Activity Relationship
D001514:Bee Venoms; D004179:Cobra Cardiotoxin Proteins; D004546:Elapid Venoms; D009498:Neurotoxins; D015222:Sodium Channels; D008555:Melitten; D008049:Lipase; D010741:Phospholipases A; D054467:Phospholipases A2